Man­u­fac­tur­ing roundup: Cana­da to in­vest $58M+ in­to 'crit­i­cal' med­i­cines man­u­fac­tur­ing; FDA to ac­cept apps for CMC pi­lot

Cana­da’s gov­ern­ment will in­vest $58.6 mil­lion over five years to sup­port the Cana­di­an Crit­i­cal Drug ini­tia­tive and 350 jobs.

The ini­tia­tive plans to boost the R&D and man­u­fac­tur­ing sec­tor in the province of Al­ber­ta and is spear­head­ed by the not-for-prof­it Ap­plied Phar­ma­ceu­ti­cal In­no­va­tion (API), which helps life sci­ence com­pa­nies in the com­mer­cial­iza­tion phase.

The fund­ing will help push for­ward a new 40,000 square foot man­u­fac­tur­ing site in Ed­mon­ton to pro­duce “crit­i­cal” med­i­cines, but the spe­cif­ic prod­ucts were not im­me­di­ate­ly an­nounced. The fa­cil­i­ty, once com­plet­ed, will be able to pro­duce 70 mil­lion dos­es an­nu­al­ly. The funds will al­so go to­ward up­grad­ing API’s ex­ist­ing R&D fa­cil­i­ty in Ed­mon­ton as well as oth­er R&D pro­grams and clin­i­cal tri­al sup­port.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER